Vanqua Bio Email Format
Biotechnology ResearchIllinois, United States11-50 Employees
Vanqua Bio is a clinical-stage biotechnology company focused on neurodegenerative diseases. Its work centers on leveraging human genetic insights to identify genes associated with the onset or progression of conditions such as Parkinson’s disease, Alzheimer’s disease, ALS, and Gaucher disease, with the aim of developing therapies that slow or halt disease progression. The company uses patient-derived neuronal cells and in vitro disease models to inform its drug-development efforts, seeking to address longstanding neuroscience challenges with a genetically informed approach. Based in Chicago, Vanqua Bio operates in the biotechnology research sector and collaborates with partners to advance its programs. Its activity includes presenting interim data from early-phase studies and engaging in partnerships to support its phase 1 work, illustrating a focus on translating genetic and cellular insights into potential therapies for neurodegenerative disorders.